Nootropic Peptides in Research: Semax, Selank, and the Russian Lineage
Nootropic Peptides in Research: Semax, Selank, and the Russian Lineage
Two of the most-studied nootropic peptides — Semax and Selank — share an unusual research history. Both were developed in Soviet-era Russian institutes, both are still used clinically in Russia today, and both have been studied internationally for cognitive and anxiolytic effects. The literature is asymmetric (heavily Russian), but the mechanisms are interesting.
Where they came from
Semax was developed at the Institute of Molecular Genetics in Moscow in the 1980s, derived from the ACTH(4-7) fragment with a Pro-Gly-Pro extension that increases stability.
Selank was developed at the same institute in the 1990s, as a synthetic 7-amino-acid analog of the natural immunomodulator tuftsin. The two compounds share a research lineage and are often discussed together.
What Semax is studied for
Cognitive performance — focus, memory consolidation, learning. Semax is used clinically in Russia for ischemic stroke recovery, with proposed mechanisms involving BDNF and NGF (nerve growth factor) modulation.
Intranasal administration is the dominant research route, leveraging direct nose-to-brain transport that bypasses first-pass metabolism.
What Selank is studied for
Anxiolytic effects — without the sedation, dependence potential, or memory impairment associated with classical anxiolytics. Proposed mechanisms involve GABAergic signaling and BDNF modulation.
Like Semax, Selank is most commonly administered intranasally in research, though injectable studies exist.
The asymmetric literature
Most published research on Semax and Selank is in Russian journals or by Russian research groups. Western replication is limited but growing.
For researchers building on either compound, the practical implication is to triangulate — mechanism studies, animal-model replications, and the small body of Western research alongside the larger Russian literature.
Related at LiveWell
Frequently asked questions
Semax vs Selank: which is better for cognition?
In research literature, Semax shows stronger effects on focus, attention, and memory. Selank shows stronger anxiolytic effects. Researchers studying combined cognitive-anxiolytic profiles often run both.
Why are nootropic peptides usually administered intranasally?
Intranasal administration leverages direct nose-to-brain transport via the olfactory and trigeminal pathways, bypassing first-pass hepatic metabolism. Most CNS-active research peptides use this route.
Are Semax and Selank FDA-approved?
No. Both are clinically used in Russia (Semax for ischemic stroke recovery; Selank as an anxiolytic) but neither has FDA approval. Research-grade material is sold for laboratory use only.
For laboratory and research use only. LiveWell Peptides products are not intended for human consumption, injection, topical application, or any other administration to the human body. This article is informational and not medical advice.